Clinical Trial Update: Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing carbetocin versus Syntometrine in obese women undergoing elective cesarean for postpartum hemorrhage has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• Carbetocin (carbetocin)
• Syntometrine (oxytocin/ergometrine)

Snippet

Sponsor: Cairo University | Conditions: Post Partum Hemorrhage | Phase 4 | Status: COMPLETED